Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Fortis Update: Radiant makes offer, Fortis forms new panel to decide proposals

      Fortis Update: Radiant makes offer, Fortis forms new panel to decide proposals

      Ruby Khatun Khatun20 April 2018 3:32 PM IST
      New Delhi: With four suitors in race, Fortis Healthcare board approved evaluation of only binding offers and formed an expert committee to evaluate...
      NABL working towards calibration of medical equipments

      NABL working towards calibration of medical equipments

      Ruby Khatun Khatun20 April 2018 2:57 PM IST
      New Delhi: The National Accreditation Board For Laboratories (NABL) is working towards calibration of medical equipments in the country to bring in...
      Glenmark gets USFDA nod for skin ointment

      Glenmark gets USFDA nod for skin ointment

      Ruby Khatun Khatun20 April 2018 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Tacrolimus ointment used for treating atopic...
      WHO recommends testing before use of Sanofis dengue vaccine

      WHO recommends testing before use of Sanofi's dengue vaccine

      Ruby Khatun Khatun20 April 2018 10:30 AM IST
      PARIS/CHICAGO: The World Health Organization (WHO) said Sanofi’s vaccine against dengue should only be used after testing on individuals to assess...
      Rs 621 crore bank fraud: 3 pharma firm directors booked

      Rs 621 crore bank fraud: 3 pharma firm directors booked

      Ruby Khatun Khatun20 April 2018 10:15 AM IST
      New Delhi: The CBI has registered a case against Surya Pharmaceuticals, its directors and officials of three companies based in Dubai and Patiala for...
      Novo Nordisk, Red Cross team up to tackle chronic diseases in conflict zones

      Novo Nordisk, Red Cross team up to tackle chronic diseases in conflict zones

      Ruby Khatun Khatun20 April 2018 9:45 AM IST
      COPENHAGEN: Danish drugmaker Novo Nordisk and aid agency Red Cross have teamed up to try to improve the treatment of chronic diseases among the...
      Roches Hemlibra gets speedy FDA review for wider use

      Roche's Hemlibra gets speedy FDA review for wider use

      Ruby Khatun Khatun20 April 2018 9:30 AM IST
      ZURICH: Roche’s hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key part of the...
      Why Family Health Insurance Plan needs a Timely Re-Evaluation?

      Why Family Health Insurance Plan needs a Timely Re-Evaluation?

      Ruby Khatun Khatun20 April 2018 9:15 AM IST
      In the day and age of today, a health insurance plan is a must for everyone. Health insurance plans need to be bought not only for adults and senior...
      Fortis Update: Munjals, Burmans better their offer, BLK promoter likely to bid

      Fortis Update: Munjals, Burmans better their offer, BLK promoter likely to bid

      Ruby Khatun Khatun19 April 2018 6:16 PM IST
      New Delhi: Fortis Healthcare said it has received an improved binding offer from Hero Enterprise Investment Office and Burman Family Office to invest...
      Ayush Drug Advertising Regulation- ASCI now part of regulatory committee

      Ayush Drug Advertising Regulation- ASCI now part of regulatory committee

      Ruby Khatun Khatun19 April 2018 10:30 AM IST
      Mumbai: Advertising sector watchdog ASCI said it is part of the ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy...
      FDA approves Crysvita for rare inherited form of rickets, x-linked hypophosphatemia

      FDA approves Crysvita for rare inherited form of rickets, x-linked hypophosphatemia

      Ruby Khatun Khatun19 April 2018 10:15 AM IST
      The U.S. Food and Drug Administration (FDA) approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older...
      Lupin gets tentative USFDA nod to market testosterone gel

      Lupin gets tentative USFDA nod to market testosterone gel

      Ruby Khatun Khatun19 April 2018 10:00 AM IST
      Mumbai: Drug firm Lupin said it has received the tentative nod from the US health regulator to market its Testosterone gel 1.62 percent.The company...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok